SRRK Scholar Rock Holding Corporation
Healthcare$51.51+7.02%ClosedMarket Cap: $6.17B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
22.19
P/S
0.00
EV/EBITDA
-13.89
DCF Value
$1.79
FCF Yield
-5.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-163.5%
ROA
-76.4%
ROIC
-85.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-102.0M | $-105.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-91.9M | $-91.0M | $— | — |
| FY null | $0.00 | NaN% | $-384.6M | $-377.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-103.5M | $-102.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-112.1M | $-110.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-77.1M | $-74.7M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-69.4M | $-66.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-252.1M | $-246.3M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-64.8M | $-64.5M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-59.5M | $-58.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-58.4M | $-56.9M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-48.0M | $-46.1M | $-0.61 | — |